U.S. flag

An official website of the United States government

NM_006941.4(SOX10):c.404G>C (p.Ser135Thr) AND Waardenburg syndrome type 2E, without neurologic involvement

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 1, 1999
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000007821.3

Allele description

NM_006941.4(SOX10):c.404G>C (p.Ser135Thr)

Genes:
POLR2F:RNA polymerase II, I and III subunit F [Gene - OMIM - HGNC]
SOX10:SRY-box transcription factor 10 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.1
Genomic location:
Preferred name:
NM_006941.4(SOX10):c.404G>C (p.Ser135Thr)
HGVS:
  • NC_000022.11:g.37983381C>G
  • NG_007948.1:g.6152G>C
  • NM_001301130.2:c.294-2773C>G
  • NM_001301131.2:c.293+16211C>G
  • NM_001363825.1:c.*38+11071C>G
  • NM_006941.4:c.404G>CMANE SELECT
  • NP_008872.1:p.Ser135Thr
  • LRG_271:g.6152G>C
  • P56693:p.Ser135Thr
Protein change:
S135T; SER135THR
Links:
UniProtKB: P56693#VAR_021386; OMIM: 602229.0005; dbSNP: rs74315515
NCBI 1000 Genomes Browser:
rs74315515
Molecular consequence:
  • NM_001301130.2:c.294-2773C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001301131.2:c.293+16211C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001363825.1:c.*38+11071C>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_006941.4:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Waardenburg syndrome type 2E, without neurologic involvement
Identifiers:
MedGen: CN069052

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000028026OMIM
no assertion criteria provided
Pathogenic
(Sep 1, 1999)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Confirmation of the Yemenite (Warburg) deaf-blind hypopigmentation syndrome.

Hennekam RC, Gorlin RJ.

Am J Med Genet. 1996 Oct 16;65(2):146-8. Review.

PubMed [citation]
PMID:
8911608

A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies.

Bondurand N, Kuhlbrodt K, Pingault V, Enderich J, Sajus M, Tommerup N, Warburg M, Hennekam RC, Read AP, Wegner M, Goossens M.

Hum Mol Genet. 1999 Sep;8(9):1785-9.

PubMed [citation]
PMID:
10441344

Details of each submission

From OMIM, SCV000028026.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a girl with a mild form of Waardenburg syndrome type 2E (611584), reported by Hennekam and Gorlin (1996), Bondurand et al. (1999) identified a heterozygous ser135-to-thr (S135T) mutation in the SOX10 gene. She had cutaneous hypo- and hyperpigmented regions and hearing loss.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 21, 2022